Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1986 Nov;41(11):840–845. doi: 10.1136/thx.41.11.840

In vitro effect of a mucolytic thiol agent on the activity of polymorphonuclear leucocyte elastase and antileucoprotease.

J Stolk, J A Kramps, J H Dijkman
PMCID: PMC460508  PMID: 3103252

Abstract

We have studied the effects of the mucolytic thiol agent mercapto-ethanesulphonate (mesna) on the activity of both polymorphonuclear leucocyte (PMN) elastase and antileucoprotease in vitro. In all tests a specific synthetic substrate was used to measure elastase activity, which was then related to enzyme activity in the absence of mesna. The relative elastase activity decreased to 67.5% of control values after the enzyme had been incubated in a 120 mmol/l mesna solution. In the sol phase of purulent sputum, elastase activity decreased to 45% after the sol phase had been incubated in a 600 mmol/l mesna solution. The inability to reverse the inhibition of mesna by increasing the substrate concentration indicated that mesna acts as a non-competitive inhibitor of PMN elastase. Incubation of elastase with antileucoprotease reduced the relative elastase activity to 21%. When antileucoprotease was preincubated in a 60 mmol/l mesna solution under identical assay conditions, a relative elastase activity of 39% was observed. Inhibition experiments with mesna treated antileucoprotease, in which sulphydryl groups were blocked with iodoacetamide, strongly suggested that the dissociation constant (Ki) of the fraction of antileucoprotease that retains activity after the incubation with mesna was not changed. Elastase inhibitory activity in mucoid sol phase, which can be ascribed mainly to antileucoprotease, decreased to 53% after incubation with mesna at a concentration of 960 mmol/l. Incubation of PMN elastase/antileucoprotease complex with mesna did not result in any release of active PMN elastase from the antileucoprotease. It is concluded that mesna and other thiol compounds, when locally administered, may influence the proteinase-antiproteinase balance in the airways by their effect on both PMN elastase and antileucoprotease.

Full text

PDF
840

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. De Water R., Willems L. N., Van Muijen G. N., Franken C., Fransen J. A., Dijkman J. H., Kramps J. A. Ultrastructural localization of bronchial antileukoprotease in central and peripheral human airways by a gold-labeling technique using monoclonal antibodies. Am Rev Respir Dis. 1986 May;133(5):882–890. [PubMed] [Google Scholar]
  2. GREEN N. M., WORK E. Pancreatic trypsin inhibitor. II. Reaction with trypsin. Biochem J. 1953 May;54(2):347–352. doi: 10.1042/bj0540347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gadek J. E., Fells G. A., Zimmerman R. L., Rennard S. I., Crystal R. G. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest. 1981 Oct;68(4):889–898. doi: 10.1172/JCI110344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gautier M., Martin J. P., Polini G. In vitro synthesis of alpha-1-antitrypsin in long term monolayer human liver cell cultures. Biomedicine. 1977 Apr;27(3):116–119. [PubMed] [Google Scholar]
  5. Hance A. J., Crystal R. G. The connective tissue of lung. Am Rev Respir Dis. 1975 Nov;112(5):657–711. doi: 10.1164/arrd.1975.112.5.657. [DOI] [PubMed] [Google Scholar]
  6. Janoff A. Biochemical links between cigarette smoking and pulmonary emphysema. J Appl Physiol Respir Environ Exerc Physiol. 1983 Aug;55(2):285–293. doi: 10.1152/jappl.1983.55.2.285. [DOI] [PubMed] [Google Scholar]
  7. Kramps J. A., van Twisk C., van der Linden A. C. L-Pyroglutamyl-L-prolyl-L-valine-p-nitroanilide, a highly specific substrate for granulocyte elastase. Scand J Clin Lab Invest. 1983 Sep;43(5):427–432. [PubMed] [Google Scholar]
  8. Ohlsson K., Tegner H., Akesson U. Isolation and partial characterization of a low molecular weight acid stable protease inhibitor from human bronchial secretion. Hoppe Seylers Z Physiol Chem. 1977 May;358(5):583–589. doi: 10.1515/bchm2.1977.358.1.583. [DOI] [PubMed] [Google Scholar]
  9. Smallman L. A., Hill S. L., Stockley R. A. Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: a serine proteinase effect. Thorax. 1984 Sep;39(9):663–667. doi: 10.1136/thx.39.9.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Spiro S., Goldstraw P. The staging of lung cancer. Thorax. 1984 Jun;39(6):401–407. doi: 10.1136/thx.39.6.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tate R. M., Repine J. E. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis. 1983 Sep;128(3):552–559. doi: 10.1164/arrd.1983.128.3.552. [DOI] [PubMed] [Google Scholar]
  12. Tegner H., Ohlsson K., Toremalm N. G., von Mecklenburg C. Effect of human leukocyte enzymes on tracheal mucosa and its mucociliary activity. Rhinology. 1979 Sep;17(3):199–206. [PubMed] [Google Scholar]
  13. Tegner H. Quantitation of human granulocyte protease inhibitors in non-purulent bronchial lavage fluids. Acta Otolaryngol. 1978 Mar-Apr;85(3-4):282–289. doi: 10.3109/00016487809111936. [DOI] [PubMed] [Google Scholar]
  14. Tschesche H., Haenisch G. Regeneration of native structure and biological activity by air oxidation of reduced pancreatic secretory trypsin inhibitor and Des-Thr-Ser-Pro-Gln-Arg-inhibitor. FEBS Lett. 1970 Dec;11(3):209–212. doi: 10.1016/0014-5793(70)80530-0. [DOI] [PubMed] [Google Scholar]
  15. Twumasi D. Y., Liener I. E. Proteases from purulent sputum. Purification and properties of the elastase and chymotrypsin-like enzymes. J Biol Chem. 1977 Mar 25;252(6):1917–1926. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES